After tragic Notre Dame fire, Sanofi pledges €10M to fix the cherished cathedral

French drugmaker Sanofi pledged €10 million to help rebuild the Notre Dame Cathedral after Monday's fire. (Pixabay)

Only days after the world wept for Paris as Notre Dame burned, France’s biggest drugmaker is pledging a €10 million to help restore the monument at the heart of its home city. 

Sanofi committed the donation via Twitter Wednesday. In a statement, CEO Olivier Brandicourt said the cathedral had “survived for centuries” and Sanofi would help make sure that doesn't change. The drugmaker “can be proud that our company is participating in its restoration for future generations,”  he said.

Sanofi joins many others contributing toward restoring the cathedral after Monday's blaze. The billionaire Pinault family started the donations with a €100 million commitment, and the Arnault family followed with a €200 million contribution, the Wall Street Journal reports.

L’Oreal and its top shareholder, the Bettencourt Meyers family, plus the Bettencourt Schueller Foundation, are giving €200 million, according to the newspaper. French oil company Total contributed €100 million as well, its CEO tweeted. And in total, the rebuilding fund reached $1 billion as of Wednesday morning, AP reports.

RELATED: The top 15 pharma companies by 2018 revenue - Sanofi

Watch the Free Webinar

Chemistry Through Biology: Translating Molecular Biology Technologies into Practical Processes for API Production

Learn about the key advances and critical hurdles in transforming emerging molecular biology technologies into practical applications with commercially viable processes.

Sanofi operates at least eight manufacturing sites and five R&D facilities in France, according to its recent annual report. The drugmaker, the seventh-largest in the world by sales, is based in Paris.

France’s president Emmanuel Macron said Tuesday the country plans to rebuild the Notre Dame Cathedral in five years. Paris hosts the Summer Olympics in 2024, so the city’s mayor, Anne Hidalgo, said “we need to do everything we can so that Notre Dame Cathedral is returned to all its splendor for this occasion,” as quoted by the Journal. One expert told the newspaper the landmark will take 15 years to fix up.

Read more on

Suggested Articles

Reblozyl, a key drug in Bristol Myers Squibb's Celgene merger, has won a key FDA nod to treat patients with myelodysplastic syndromes.

Wealthy individuals typically don't set out to waste billions of dollars, but amid the COVID-19 pandemic, that’s exactly what Bill Gates plans to do.

GSK's Nucala is hoping to parlay positive phase 3 data in nasal polyps into a first-of-its-kind approval for the IL-5 class.